CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,856 enrolled
Drug / intervention
ALL +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02299791
NCT02299791N/ACompleted

Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics

Kaiser Permanente·interventional·Posted Nov 24, 2014·Updated Oct 4, 2017

In Brief

A clinical study evaluating ALL for Diabetes Mellitus and Cardiovascular Diseases. Completed, enrolled 4,856 participants.

Detailed Summary

The purpose of the ALL Study is to determine the effectiveness of the dissemination of the ALL intervention from an integrated care setting into Community Health Centers (CHCs) by measuring changes in diabetes mellitus (DM) population prescription rates for the medications, using a pre-post comparison within clinics and a staggered, randomized implementation across clinics.

Study Details

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 24, 2014
Enrollment StartSep 1, 2010
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 11.6 years ago

Interventions

ALLother

This clinic-level intervention involves a toolkit of decision support tools. These tools are listed below. 1. EHR tools to expedite identification a. EHR automated point-of-care alerts (Best Practice Alerts) 2. EHR tools to expedite prescribing 1. EHR order sets 2. EHR text shortcuts for notation 3. patient education materials (handout, poster) 3. EHR-based outreach support tools a. EHR registries

ALLother

These clinics got the same exact intervention, but one year later, as this was a staggered randomized trial.